[1]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-US2009/124595,2009,A1Locationinpatent:Page/Pagecolumn33
[2]Dannhardt;Meindl;Gussmann;Ajili;Kappe[EuropeanJournalofMedicinalChemistry,1987,vol.22,#6,p.505-510]
[1]Dannhardt;Meindl;Gussmann;Ajili;Kappe[EuropeanJournalofMedicinalChemistry,1987,vol.22,#6,p.505-510]
[1]Dannhardt;Meindl;Gussmann;Ajili;Kappe[EuropeanJournalofMedicinalChemistry,1987,vol.22,#6,p.505-510]
[2]Christoforow,Andreas;Wilke,Julian;Binici,Aylin;Pahl,Axel;Ostermann,Claude;Sievers,Sonja;Waldmann,Herbert[AngewandteChemie-InternationalEdition,2019,vol.58,#41,p.14715-14723][Angew.Chem.,2019,vol.131,#41,p.14857-14865,9]
[1]Dannhardt;Meindl;Gussmann;Ajili;Kappe[EuropeanJournalofMedicinalChemistry,1987,vol.22,#6,p.505-510]
Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Journal: Bioorganic & medicinal chemistry letters 20101101